Company Filing History:
Years Active: 2017
Title: Valerie Cesson: Innovator in Immunology
Introduction
Valerie Cesson is a prominent inventor based in Saint-Gingolph, France. She has made significant contributions to the field of immunology, particularly through her innovative work on targeted CD1d molecules. Her research focuses on enhancing immune responses, which has important implications for cancer treatment and autoimmune diseases.
Latest Patents
Valerie Cesson holds a patent for her invention titled "Targeted CD1d molecules." This invention is directed to a compound comprising one or more CD1d complexes in association with an antibody specific for a cell surface marker. The CD1d complexes consist of a CD1d molecule, a β2-microglobulin molecule, and may further include an antigen bound to the CD1d binding groove. The invention also outlines methods for inhibiting or stimulating immune responses using the CD1d-antibody compounds, particularly in the context of anti-tumor and autoimmunity responses. She has 1 patent to her name.
Career Highlights
Valerie Cesson is currently associated with Vaccinex, Inc., where she continues her groundbreaking research. Her work has positioned her as a key figure in the development of novel immunotherapeutic strategies.
Collaborations
Throughout her career, Valerie has collaborated with notable colleagues, including Bruno Robert and Alena Donda. These partnerships have further enriched her research and contributed to advancements in the field.
Conclusion
Valerie Cesson's innovative work in immunology, particularly her patent on targeted CD1d molecules, showcases her commitment to advancing medical science. Her contributions have the potential to significantly impact the treatment of various diseases, making her a noteworthy inventor in her field.